Perceptive Advisors LLC
- SEC CIK
- 0001224962
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 102
- −5 vs. Q2 2024
- Portfolio value
- $4.66B
- +$517.8M (+12.5%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| NUVLNuvalent, Inc. | COM | 2,979,235 | $304.8M | 6.5% | +430,158+16.9% | Added | History |
| ACLXArcellx, Inc. | COMMON STOCK | 3,888,669 | $324.7M | 7.0% | −1,0700.0% | Reduced | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q2 2024 (18)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| CERECerevel Therapeutics Holdings, Inc. | COM | 10,794,876 | $441.4M | 10.7% | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 264,600 | $74.1M | 1.8% | History |
| BBIOBridgeBio Pharma, Inc. | COM | 1,215,346 | $30.8M | 0.7% | History |
| CGEMCullinan Therapeutics, Inc. | COM | 749,916 | $13.1M | 0.3% | History |
| TEMTempus AI, Inc. | CL A | 275,000 | $9.63M | 0.2% | History |
| ENGNenGene Therapeutics Inc. | COM | 800,000 | $7.54M | 0.2% | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 867,319 | $7.38M | 0.2% | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 500,000 | $5.89M | 0.1% | History |
| RXRXRecursion Pharmaceuticals, Inc. | CL A | 769,230 | $5.77M | 0.1% | History |
| CABACabaletta Bio, Inc. | COM | 585,045 | $4.38M | 0.1% | History |
| SKYESkye Bioscience, Inc. | COM NEW | 500,000 | $4.00M | 0.1% | History |
| FHTXFoghorn Therapeutics Inc. | COM | 544,000 | $3.13M | 0.1% | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 22,665 | $2.10M | 0.1% | – |
| RVNCRevance Therapeutics, Inc. | COM | 600,000 | $1.54M | <0.1% | History |
| EGRXEagle Pharmaceuticals, Inc. | COM | 173,365 | $970.8K | <0.1% | History |
| VBIVVBI Vaccines Inc/BC | COM | 1,261,710 | $832.7K | <0.1% | History |
| TCMDTactile Systems Technology Inc | COM | 62,639 | $747.9K | <0.1% | History |
| AXGNAxogen, Inc. | COM | 30,421 | $220.2K | <0.1% | History |